Related content

Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: A 13-week, randomized, double-blind, placebo-controlled, fixed-dose study

By Casas Miguel  

World Journal of Biological Psychiatry, Vol. 14, Iss. 4, 2013-05 ,pp. : 268-281

Informa Healthcare

Access to resources Recommend Favorite

Motor excitability and motor behaviour after modafinil ingestion – a double-blind placebo-controlled cross-over trial

By Liepert J.   Allstadt-Schmitz J.   Weiller C.  

Journal of Neural Transmission, Vol. 111, Iss. 6, 2004-06 ,pp. : 703-711

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of spasticity with repetitive magnetic stimulation; a double-blind placebo-controlled study

By Nielsen J.F.   Sinkjaelig r T.   Jakobsen J.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 142-142

Elsevier

Access to resources Recommend Favorite

Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study

By Sandrini Giorgio  

The Journal of Headache and Pain, Vol. 12, Iss. 4, 2011-08 ,pp. : 427-433

Springer Publishing Company

Access to resources Recommend Favorite

Does modafinil enhance activity of patients with myotonic dystrophy?: A double-blind placebo-controlled crossover study

By Wintzen A.R.   Lammers G.J.   Dijk J.G.  

Journal of Neurology, Vol. 254, Iss. 1, 2007-01 ,pp. : 26-28

Springer Publishing Company

Access to resources Recommend Favorite